PILOT STUDY OF BMY-42215-1 (15-DEOXYSPERGUALIN TRIHYDROCHLORIDE)

BMY-42215-1（15-脱氧精胍菌素三盐酸盐）的试点研究

• 批准号: 5218074
• 负责人: Dixon B Kaufman
• 金额: --
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/5218074
• 关键词: clinical research; diabetes mellitus therapy; human subject; human therapy evaluation; immunosuppressive; insulin dependent diabetes mellitus; kidney transplantation; pancreatic islet transplantation

The primary goal of this pilot study is to achieve long-term (>1 year) insulin independence by transplanting cadaver adult islets, aided by a new immuno-suppressive agent, 15-deoxyspergualin (DSG), in patients that have previously received a successful kidney transplant, but remain C-peptide negative, type I diabetics.

本初步研究的主要目标是实现长期（10 - 10年）